Home › BIO Issues Statement on Hepatitis C medicines report.
 

Keywords :   


BIO Issues Statement on Hepatitis C medicines report.

2015-12-07 14:31:08| Industrial Newsroom - All News for Today

In his statement regarding report released by Senators Grassley and Wyden, BIO Senior VP of Communications Kenneth Lisaius stated that BIO is reviewing said report in full and generally does not comment on product pricing by member companies. Lisaius added, however, that "balanced debate about the cost of groundbreaking cures" cannot narrow their focus on price but also acknowledge value provided to patients as well as overall healthcare system.

Tags: report issues statement bio

Category:Industrial Goods and Services

Latest from this category

All news
01.05Will Artificial Intelligence Be the End of Reps? Part 2
Industrial Goods and Services »
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
11.05LG CHI Color Master Factory Is Awarded Patent
11.05AgriWebb raises $7.2m to fuel further innovation in sustainable beef production
11.05YouGov Unveils Americans Skincare Routines
11.05Naples Soap Company Reports Revenue Surge Amidst Tourist Season
11.05Indian Perfume Brand Eze Perfumes Enters US Market
11.05LOccitane Travel Retail Showcases Travel Retail Brand Portfolio at TFWA Asia Pacific
10.05How crops are being disaster-proofed
More »